| Supplementary Information for | |||||||||||||||||||
| Vreven, T, Moal, IH, Vangone, A, Pierce, BG, Kastritis, PL, Torchala, M, Chaleil, R, Jimenez-Garcia, B, Bates, PA, Fernandez-Recio, J, Bonvin, AMJJ and Weng, Z., | |||||||||||||||||||
| Updates to the integrated protein-protein interaction benchmarks: Docking benchmark version 5 and affinity benchmark version 2. (Journal of Molecular Biology, 2015, vol. 427, p. 3031-41) | |||||||||||||||||||
| Guest, JD, Vreven, T, Zhou, J, Moal, I, Jeliazkovd, JR, Gray, JJ, Weng, Z and Pierce, BG | |||||||||||||||||||
| An Expanded Benchmark for Antibody-Antigen Docking and Affinity Prediction Reveals Insights into Antibody Recognition Determinants (submitted) | |||||||||||||||||||
| This work is licensed under a Creative Commons Attribution 4.0 International License | |||||||||||||||||||
| Also see the GitHub repository of the Pierce lab | |||||||||||||||||||
| Download cleaned-up PDB files for the benchmark in a gzipped archive | Download Table in excel file | ||||||||||||||||||
| Follow the "info" link in the leftmost column to view bound/unbound chain BLAST alignments and | |||||||||||||||||||
| potentially useful comments about individual benchmark cases | |||||||||||||||||||
| Table: Protein-Protein Docking Benchmark 5.5 | |||||||||||||||||||
| +Info | Complex | Cat.a | PDBid 1 | Protein 1 | HETATMs | PDBid 2 | Protein 2 | HETATMs | RMSDb(Å) | DASAc(Å2) | Multimer | ||||||||
| Rigid-body (162) | |||||||||||||||||||
| info | 1AHW_AB:C | AA | 1FGN_LH | Fab 5g9 | 1TFH_A | Tissue factor | 0.69 | 1899 | |||||||||||
| info | 1DQJ_AB:C | AA | 1DQQ_CD | Fab Hyhel63 | 3LZT_ | HEW lysozyme | 0.75 | 1765 | |||||||||||
| info | 1E6J_HL:P | AA | 1E6O_HL | Fab | 1A43_ | HIV-1 capsid protein p24 | 1.05 | 1245 | |||||||||||
| info | 1JPS_HL:T | AA | 1JPT_HL | Fab D3H44 | 1TFH_B | Tissue factor | 0.51 | 1852 | |||||||||||
| info | 1MLC_AB:E | AA | 1MLB_AB | Fab44.1 | 3LZT_ | HEW lysozyme | 0.6 | 1392 | |||||||||||
| info | 1S78_DC:A | AA | 1L7I_HL | pertuzumab (Perjeta) | 2A91_A | ErbB2 | 1.13 | 2175 | |||||||||||
| info | 1VFB_AB:C | AA | 1VFA_AB | Fv D1.3 | 8LYZ_ | HEW lysozyme | 1.02 | 1383 | |||||||||||
| info | 1WEJ_HL:F | AA | 1QBL_HL | Fab E8 | 1HRC_ | Cytochrome C | HEM,ACE | 0.31 | 1177 | ||||||||||
| info | 2FD6_HL:U | AA | 2FAT_HL | Plasminogen receptor antibody | 1YWH_A | Plasminogen activator receptor | 1.07 | 1139 | |||||||||||
| info | 2I25_N:L | AS | 2I24_N | Shark single domain antigen receptor | 3LZT | Lysozyme | 1.21 | 1425 | |||||||||||
| info | 2VIS_AB:C | AA | 1GIG_LH | Fab | 2VIU_ACE | Flu virus hemagglutinin | 0.8 | 1296 | Ligand Trimer Created | ||||||||||
| info | 2VXT_HL:I | AA | 2VXU_HL | Murine reference antibody 125-2H FAB | 1J0S_A(6) | Interleukin-18 | 1.33 | 2163 | |||||||||||
| info | 2W9E_HL:A | AA | 2W9D_HL | ICSM 18 FAB fragment | 1QM1_A | Prion protein fragment | 1.13 | 1677 | |||||||||||
| info | 3EOA_LH:I | AA | 3EO9_LH | Efalizumab FAB fragment | 3F74_A | Integrin alpha-L I domain | 0.39 | 1272 | |||||||||||
| info | 3HMX_LH:AB | AA | 3HMW_LH | Ustekinumab FAB | 1F45_AB | Interleukin-12 | 0.73 | 1841 | |||||||||||
| info | 3MJ9_HL:A | AA | 3MJ8_HL | HL4E10 | 3MJ6_A | JAML | 1.48 | 2457 | |||||||||||
| info | 3MXW_LH:A | AA | 3MXV_LH | Anti-Shh 5E1 chimera FAB fragment | 3M1N_A | Sonic Hedgehog N-terminal domain | 0.48 | 1696 | |||||||||||
| info | 3RVW_CD:A | AA | 3RVT_CD | 4C1 FAB | 3F5V_A | DER P 1 allergen | 0.5 | 1383 | |||||||||||
| info | 3SE8_HL:G | AA | 5JXA_HL | VRC03 | 3TGT_A | HIV 93TH057 gp120 | 1.22 | 2690 | |||||||||||
| info | 3U7Y_HL:G | AA | 3U7W_HL | NIH45-46 | 3TGT_A | HIV 93TH057 gp120 | 0.84 | 2544 | |||||||||||
| info | 3WD5_HL:ABC | AA | 4NYL_HL | adalimumab (Humira) | 1TNF_ABC | TNFalpha | 0.93 | 2328 | Complex Trimer Created | ||||||||||
| info | 4DN4_LH:M | AA | 4DN3_LH | CNTO888 FAB | 1DOL_A | MCP-1 | 0.81 | 1317 | |||||||||||
| info | 4FP8_HL:A | AA | 4FNL_HL | C05 | 4FNK_ABCDEF | influenza H3 HA | 0.34 | 1322 | |||||||||||
| info | 4FQI_HL:ABEFCD | AA | 4FQH_HL | CR9114 FAB | 2FK0_ABCDEF | H5N1 influenza virus hemagglutinin | 1.08 | 1459 | Complex Ligand Hexamer Created | ||||||||||
| info | 4G6J_HL:A | AA | 4G5Z_HL | Canakinumab antibody fragment | 4I1B_A | Interleukin-1 beta | 0.61 | 1893 | |||||||||||
| info | 4G6M_HL:A | AA | 4G6K_HL | Gevokizumab antibody fragment | 4I1B_A | Interleukin-1 beta | 0.49 | 1673 | |||||||||||
| info | 4GXU_MN:ABEFCD | AA | 4GXV_HL | 1F1 antibody | 1RUZ_HIJKLM | 1918 H1 Hemagglutinin | 0.78 | 1830 | |||||||||||
| info | 4M5Z_HL:A | AA | 4M5Y_HL | 5J8 | 3UYX_A | influenza H1N1 HA1 | 0.73 | 1591 | |||||||||||
| info | 4Y7M_A:C | AS | 4QGY_A | nb25 | 4Y7L_A | E coli TssM CTD | 0.84 | 1103 | |||||||||||
| info | 5GRJ_HL:A | AA | 4NKI_HL | avelumab scFv (Bavencio) | 4Z18_A | PD-L1 | 1.14 | 1753 | |||||||||||
| info | 5JMO_D:B | AS | 5JMR_A | Nb14 | 5JXI_A | Furin | 0.29 | 1394 | |||||||||||
| info | 5O14_HL:A | AA | 5UR8_AB | 1A12 | 3KVD_D | Neisseria meningitidis fHbp | 0.63 | 1524 | |||||||||||
| info | 5O1R_HL:A | AA | 5NYX_HL | 5H2 | 6CUJ_A | Neisseria meningitidis NHBA | 0.90 | 1852 | |||||||||||
| info | 5SV3_C:D | AS | 5SV4_A | A3C8 | 1IFT_A | Ricin | 0.57 | 1294 | |||||||||||
| info | 5WK3_WV:D | AA | 5WK2_HL | M116 | 1NR4_A | CCL17 | 0.57 | 1222 | |||||||||||
| info | 5WUX_HL:EFG | AA | 5WUV_HL | certolizumab (Cimzia) | 1TNF_CBA | TNFalpha | 0.80 | 2073 | |||||||||||
| info | 5X0T_AB:E | AA | 5X4G_AB | 6H8 | 3B5H_A | CD147 | 1.25 | 1316 | |||||||||||
| info | 5Y9J_HL:ABC | AA | 5Y9K_HL | belimumab (Benlysta) | 1KXG_ABC | B lymphocyte stimulator | 0.96 | 1976 | Complex Trimer Created | ||||||||||
| info | 6A77_HL:A | AA | 6A76_HL | B5209B | 5O5I_A | ROBO1 Ig5 | 0.95 | 1533 | |||||||||||
| info | 6B0S_HL:C | AA | 6B0W_HL | 1710 Fab fragment | 3VDJ_A | circumsporozoite protein aTSR domain | 0.72 | 1353 | |||||||||||
| info | 6BPC_EF:D | AA | 6BPB_AB | 4F7 | 5W53_A | Plasmodium vivax reticulocyte-binding protein 2b | 0.47 | 1645 | |||||||||||
| info | 6CWG_B:A | AS | 6CWK_A | A9 | 1IFT_A | Ricin | 0.76 | 1151 | |||||||||||
| info | 6DBG_C:B | AS | 6DBA_A | R303 | 1H6T_A | Listeria monocytogenes internalin B | 0.46 | 1525 | |||||||||||
| info | 6OC3_AB:F | AA | 6OBZ_HL | FluA-20 | 6CHX_A | H1 hemagglutinin head | 0.59 | 1537 | |||||||||||
| info | 1AVX_A:B | EI | 1QQU_A | Porcine trypsin | 1BA7_B | Soybean trypsin inhibitor | 0.47 | 1585 | |||||||||||
| info | 1AY7_A:B | EI | 1RGH_B | RNase Sa | 1A19_B | Barstar | 0.54 | 1237 | |||||||||||
| info | 1BUH_A:B | EI | 1HCL_ | CDK2 kinase | 1DKS_A | Ckshs1 | 0.75 | 1324 | |||||||||||
| info | 1BVN_P:T | EI | 1PIG_ | a-amylase | 1HOE_ | Tendamistat | 0.87 | 2222 | |||||||||||
| info | 1CLV_A:I | EI | 1JAE_A | a-amylase | 1QFD_A(1) | a-amylase inhibitor | 0.86 | 2087 | |||||||||||
| info | 1D6R_A:I | EI | 2TGT_ | Bovine trypsin | 1K9B_A | Bowman-Birk inhibitor | 1.14 | 1408 | |||||||||||
| info | 1DFJ_E:I | EI | 9RSA_B | Ribonuclease A | 2BNH_ | Rnase inhibitor | ACE | 1.02 | 2582 | ||||||||||
| info | 1E6E_A:B | ES | 1E1N_A | Adrenoxin reductase | FAD | 1CJE_D | Adrenoxin | 0.96 | 2315 | ||||||||||
| info | 1EAW_A:B | EI | 1EAX_A | Matriptase | 9PTI_ | BPTI | 0.54 | 1866 | |||||||||||
| info | 1EWY_A:C | ES | 1GJR_A | Ferredoxin reductase | FAD | 1CZP_A | Ferredoxin | 0.8 | 1502 | ||||||||||
| info | 1EZU_C:AB * | EI | 1TRM_A | D102N Trypsin | 1ECZ_AB | Ecotin | 1.21 | 2751 | |||||||||||
| info | 1F34_A:B | EI | 4PEP_ | Porcine pepsin | 1F32_A | Ascaris inhibitor 3 | 0.93 | 3038 | |||||||||||
| info | 1F51_AB:E | ER | 1IXM_AB | Sporulation response factor B | 1SRR_C | Sporulation response factor F | 0.74 | 2407 | |||||||||||
| info | 1FLE_E:I | EI | 9EST_A | Elastase | 2REL_A(4) | Elafin | 1.02 | 1763 | |||||||||||
| info | 1GL1_A:I | EI | 1K2I_1 | a-chymotrypsin | 1PMC_A(6) | Protease inhibitor LCMI II | 1.21 | 1591 | |||||||||||
| info | 1GLA_G:F | ER | 1BU6_O | Glycerol Kinase | 1F3Z_A | Glucose specific phosphocarrier | 0.98 | 1304 | |||||||||||
| info | 1GXD_A:C | EI | 1CK7_A | proMMP2 type IV collagenase | 1BR9_A | Metalloproteinase inhibitor 2 | 1.39 | 2445 | |||||||||||
| info | 1HIA_AB:I | EI | 2PKA_XY | Kallikrein | 1BX8_ | Hirustatin | 1.4 | 1737 | |||||||||||
| info | 1JTD_B:A | EI | 3QI0_A | BLIP-II | 1BTL_A | TEM-1 beta-lactamase | 0.44 | 2180 | |||||||||||
| info | 1JTG_B:A | EI | 3GMU_B | Beta-lactamase inhibitor protein | 1ZG4_A | Beta-lactamase TEM-1 | 0.49 | 2600 | |||||||||||
| info | 1JWH_CD:A | ER | 3EED_AB | Casein kinase II beta chain | 3C13_A | Casein kinase II a chain | EMO | 1.27 | 1452 | ||||||||||
| info | 1MAH_A:F | EI | 1J06_B | Acetylcholinesterase | 1FSC_ | Fasciculin | 0.61 | 2145 | |||||||||||
| info | 1OC0_A:B | ER | 1B3K_A | Plasminogen activator inhibitor-1 | 2JQ8_A(4) | Vitronectin Somatomedin B domain | 1 | 1313 | |||||||||||
| info | 1OPH_A:B | EI | 1QLP_A | a-1-antitrypsin | 1UTQ_A | Trypsinogen | 1.21 | 1360 | |||||||||||
| info | 1OYV_A:I | EI | 1SCD_A | Subtilisin Carlsberg | 1PJU_A | Two-headed tomato inhibitor-II | 0.7 | 1930 | |||||||||||
| info | 1OYV_B:I | EI | 1SCD_A | Subtilisin Carlsberg | 1PJU_A | Two-headed tomato inhibitor-II | 0.47 | 1280 | |||||||||||
| info | 1PPE_E:I | EI | 1BTP_ | Bovine trypsin | 1LU0_A | CMTI-1 squash inhibitor | 0.44 | 1688 | |||||||||||
| info | 1R0R_E:I | EI | 1SCN_E | Subtilisin carlsberg | 2GKR_I | OMTKY | 0.45 | 1409 | |||||||||||
| info | 1TMQ_A:B | EI | 1JAE_ | alpha-amylase | 5HP | 1B1U_A | RAGI inhibitor | 0.86 | 2401 | ||||||||||
| info | 1UDI_E:I | EI | 1UDH_ | Uracyl-DNA glycosylase | 2UGI_B | Glycosylase inhibitor | 0.9 | 2022 | |||||||||||
| info | 1US7_A:B | ER | 2FXS_A | Heat shock protein 82 N-ter domain | 2W0G_A | HSP 90 co-chaperone CDC37 C-ter domain | 1.06 | 1095 | |||||||||||
| info | 1WDW_BD:A | ER | 1V8Z_AB | Tryptophan synthase beta chain 1 | 1GEQ_A | Tryptophan synthase alpha chain | 1.29 | 3148 | |||||||||||
| info | 1YVB_A:I | EI | 2GHU_A | Falcipain 2 | 1CEW_I | Cystatin | 0.51 | 1743 | |||||||||||
| info | 1Z5Y_D:E | ES | 1L6P | N-term of DsbD | 2B1K_A | E.coli CCMG protein | 1.23 | 1346 | |||||||||||
| info | 2A1A_B:A | ES | 3UIU_A | Eukayotic translation initiation factor 2-alpha kinase 2 | 1Q46_A | eIF2 alpha subunit | 1.35 | 1186 | |||||||||||
| info | 2A9K_A:B | ES | 1U90_A | Ras-related protein Ral-A | GDP | 2C8B_X | Mono-ADP-ribosyltransferase C3 | 0.85 | 1751 | ||||||||||
| info | 2ABZ_B:E | EI | 3I1U_A | Carboxypeptidase A1 | 1ZFI_A(1) | Leech carboxypeptidase inhibitor | 0.9 | 1443 | |||||||||||
| info | 2AYO_A:B | ER | 2AYN_A | Ubiquitin carboxyl-terminal hydrolase 14 | 2FCN_A | Ubiquitin | 1.39 | 3027 | |||||||||||
| info | 2B42_B:A | EI | 2DCY_A | Xylanase | 1T6E_X | Xylanase inhibitor | 0.72 | 2520 | |||||||||||
| info | 2GAF_D:A | ER | 3OWG_A | Poly(A) polymerase VP55 | 1VPT_A | Vaccinia protein VP39 | MSE | 0.69 | 3368 | ||||||||||
| info | 2J0T_A:D | EI | 966C_A | MMP1 Intersitial collagenase | 1D2B_A(20) | Metalloproteinase inhibitor 1 | 1.23 | 1477 | |||||||||||
| info | 2MTA_HL:A | ES | 2BBK_JM | Methylamine dehydrogenase | 2RAC_A | Amicyanin | 0.41 | 1461 | |||||||||||
| info | 2O8V_A:B | ES | 1SUR_A | PAPS reductase | 2TRX_A | Thioredoxin | 1.37 | 1619 | |||||||||||
| info | 2OOB_A:B | ES | 2OOA_A | Ubiquitin ligase | 1YJ1_A | Ubiquitin | 0.85 | 808 | |||||||||||
| info | 2OOR_AB:C | ER | 1L7E_AB | NAD(P) transhydrogenase subunit a part 1 | 1E3T_A | NAD(P) transhydrogenase subunit beta | NAP | 1.42 | 2065 | ||||||||||
| info | 2OUL_A:B | EI | 3BPF_A | Falcipain 2 | 2NNR_A | Chagasin | 0.53 | 1933 | |||||||||||
| info | 2PCC_A:B | ES | 1CCP_ | Cyt C peroxidase | HEM | 1YCC_ | Cytochrome C | HEM | 0.39 | 1141 | |||||||||
| info | 2SIC_E:I | EI | 1SUP_ | Subtilisin | 3SSI_ | Streptomyces subtilisin inhibitor | 0.36 | 1617 | |||||||||||
| info | 2SNI_E:I | EI | 1UBN_A | Subtilisin | SOC | 2CI2_I | Chymotrypsin inhibitor 2 | 0.35 | 1628 | ||||||||||
| info | 2UUY_A:B | EI | 1HJ9_A | Trypsin | 2UUX_A | Tryptase inhibitor from tick | 0.43 | 1280 | |||||||||||
| info | 2YVJ_A:B | ER | 2YVF_A | Ferredoxin reductase BPHA4 | FAD,NAI,NAD | 2E4P_A | Biphenyl dioxygenase ferredoxin subunit | FES | 0.6 | 1377 | |||||||||
| info | 3A4S_A:D | EI | 1A3S_A | SUMO-conjugating enzyme UBC9 | 3A4R_A | NFATC2-interacting protein SLD2 ubiquitin-like domain | 0.72 | 1116 | |||||||||||
| info | 3K75_D:B | ER | 1BPB_A | DNA polymerase beta | 3K77_A | Reduced XRCC1, N-terminal domain | 0.64 | 1195 | |||||||||||
| info | 3LVK_AC:B | ER | 3LVM_AB | Cysteine desulfurase IscS | PLP | 1DCJ_A(12) | Sulfurtransferase tusA | 0.81 | 1609 | Complex Receptor Dimer Created | |||||||||
| info | 3PC8_A:C | ER | 3PC6_A | DNA repair protein XRCC1 | 3PC7_A | DNA ligase III-alpha BRCT domain | MSE | 0.5 | 1240 | ||||||||||
| info | 3SGQ_E:I | EI | 2QA9_E | Streptogrisin B | 2OVO_A | Ovomucoid inhibitor third domain | 0.39 | 1211 | |||||||||||
| info | 3VLB_A:B | EI | 3VLA_A | EDGP | 3VL8_A | Xyloglucan-specific endo-beta-1,4-glucanase A | 0.51 | 2020 | |||||||||||
| info | 4CPA_A:I | EI | 8CPA_A | Carboxypeptidase A | 1H20_A(9) | Potato carboxypeptidase inhibitor | 0.62 | 1175 | |||||||||||
| info | 4H03_A:B | ES | 1GIQ_A | Iota toxin component IA | NAD,NAI | 1IJJ_A | Alpha actin | ATP | 0.68 | 1474 | |||||||||
| info | 4HX3_BD:A | EI | 4HWX_AB | Neutral proteinase inhibitor ScNPI | 1C7K_A | Zinc endoprotease | 0.9 | 2086 | Receptor Dimer Created | ||||||||||
| info | 7CEI_A:B | EI | 1UNK_D | Colicin E7 nuclease | 1M08_B | Im7 immunity protein | 0.7 | 1384 | |||||||||||
| info | 1A2K_C:AB | OG | 1QG4_A | Ran GTPase | GDP | 1OUN_AB | Nuclear transport factor 2 | 1.11 | 1603 | ||||||||||
| info | 1AK4_A:D | OX | 2CPL_ | Cyclophilin | 4J93_A | HIV capsid | 0.87 | 1029 | |||||||||||
| info | 1AKJ_AB:DE | OX | 2CLR_DE | MHC class 1 HLA-A2 | 1CD8_AB | T-cell CD8 coreceptor | 1.14 | 1995 | Ligand Dimer Created | ||||||||||
| info | 1AZS_AB:C | OG | 1AB8_AB | Adenylyl cyclase | 1AZT_A | AC activator Gs a complex | GSP | 0.72 | 1911 | ||||||||||
| info | 1E96_A:B | OG | 1MH1_ | Rac GTPase | GNP | 1HH8_A | p67 Phox | 0.71 | 1179 | ||||||||||
| info | 1EFN_B:A | OX | 1AVV_A | HIV-1-NEF protein | 1G83_A | SH3 domain | 0.77 | 1254 | |||||||||||
| info | 1EXB_ABDC:EGFH | OX | 1QRQ_ABCD | KV beta2 protein beta subunit | NDP | 1QDV_ABCD | KV1.2 potassium channel N-terminal domain | 0.62 | 3558 | Complex Dimer of Tetramers Created | |||||||||
| info | 1FCC_AB:C | OX | 1FC1_AB | Fc domain of IgG1 MO61 | 2IGG_A(3) | Strep. protein G C2 fragment | 0.93 | 1354 | |||||||||||
| info | 1FFW_A:B | OX | 3CHY_A | Chemotaxis protein CheY | 1FWP_A | Chemotaxis protein CheA | 1.43 | 1166 | |||||||||||
| info | 1FQJ_A:B | OG | 1TND_C | Gt-alpha | GSP | 1FQI_A | RGS9 | MSE | 0.91 | 1806 | |||||||||
| info | 1GCQ_B:C | OX | 1GRI_B | GRB2 C-ter SH3 domain | 1GCP_B | Vav N-ter SH3 domain | 0.92 | 1208 | |||||||||||
| info | 1GHQ_A:B | OR | 1C3D_ | Complement C3 | 1LY2_A | Epstein-Barr virus receptor CR2 | 0.34 | 800 | |||||||||||
| info | 1GPW_A:B | OX | 1THF_D | HISF protein | 1K9V_F | Amidotransferase HISH | 0.65 | 2097 | |||||||||||
| info | 1H9D_A:B | OX | 1EAN_A | Runx1 domain of CBFa1 | 1ILF_A(1) | Dimerisation domain of CBF-beta | 1.32 | 2121 | |||||||||||
| info | 1HCF_AB:X | OR | 1B98_AM | Neurotrophin-4 | 1WWB_X | TrkB-d5 growth factor receptor | 0.88 | 2136 | |||||||||||
| info | 1HE1_C:A | OG | 1MH1_ | Rac GTPase | GNP | 1HE9_A | Pseudomonas toxin GAP dom. | MES | 0.93 | 2113 | |||||||||
| info | 1I4D_D:AB | OG | 1MH1_ | Rac GTPase | GNP | 1I49_AB | Arfaptin | 1.41 | 1657 | ||||||||||
| info | 1J2J_A:B | OG | 1O3Y_A | Arf1 GTPase | GTP | 1OXZ_A | GAT domain of GGA1 | 0.63 | 1209 | ||||||||||
| info | 1K74_AB:DE | OR | 1MZN_AB | RXR-a | 1ZGY_AB | PPAR-gamma | 0.8 | 2200 | |||||||||||
| info | 1KAC_A:B | OR | 1NOB_F | Adenovirus fiber knob protein | 1F5W_B | Adenovirus receptor | 0.95 | 1456 | |||||||||||
| info | 1KLU_AB:D | OX | 1H15_AB | MHC class 2 HLA-DR1 | 1STE_ | Staphylococcus enterotoxin C3 | 0.43 | 1254 | |||||||||||
| info | 1KTZ_A:B | OR | 1TGK_ | TGF-beta | 1M9Z_A | TGF-beta receptor | 0.39 | 989 | |||||||||||
| info | 1KXP_A:D | OX | 1IJJ_B | Actin | ATP | 1KW2_B | Vitamin D binding protein | 1.12 | 3341 | ||||||||||
| info | 1M27_AB:C | OX | 1D4T_AB | SAP-SLAM Complex | 3UA6_A | Fyn kinase SH3 domain | 1.22 | 799 | |||||||||||
| info | 1ML0_AB:D | OR | 1MKF_AB | Viral chemokine binding p. M3 | 1DOL_ | Chemokine Mcp1 | 1.02 | 2069 | Complex Receptor Dimer Created | ||||||||||
| info | 1OFU_XY:A | OX | 1OFT_AB | SulA (PA3008) | 2VAW_A | Cell division protein FtsZ | GDP | 1.1 | 1583 | ||||||||||
| info | 1PVH_A:B | OR | 1BQU_A | IL6 receptor beta chain D2-D3 domains | 1EMR_A | Leukemia inhibitory factor | 0.34 | 1403 | |||||||||||
| info | 1QA9_A:B | OX | 1HNF_ | CD2 | 1CCZ_A | CD58 | 0.73 | 1353 | |||||||||||
| info | 1RLB_ABCD:E | OX | 2PAB_ABCD | Transthyretin | 1HBP_ | Retinol binding protein | RTL | 0.66 | 1439 | Receptor Tetramer Created | |||||||||
| info | 1RV6_VW:X | OR | 1FZV_AB | PIGF receptor binding domain | 1QSZ_A | Flt1 protein domain 2 | 1.09 | 1626 | |||||||||||
| info | 1S1Q_A:B | OX | 2F0R_A | UEV domain | 1YJ1_A | Ubiquitin | 0.98 | 1288 | |||||||||||
| info | 1SBB_A:B | OR | 1BEC_ | T-cell receptor beta | 1SE4_ | Staphylococcus enterotoxin B | 0.37 | 1064 | |||||||||||
| info | 1T6B_X:Y | OR | 1ACC_A | Anthrax protective antigen | 1SHU_X | Anthrax toxin receptor | 0.62 | 1948 | |||||||||||
| info | 1XD3_A:B | OX | 1UCH | UCH-L3 | 1YJ1_A | Ubiquitin | 1.24 | 2281 | |||||||||||
| info | 1XU1_ABD:T | OR | 1U5Y_ABD | TNF domain of APRIL | 1XUT_A(11) | TNF receptor superfamily member 13B TACI CRD2 domain | 1.3 | 1697 | |||||||||||
| info | 1Z0K_A:B | OG | 2BME_A | Rab4A GTPase | GNP | 1YZM_A | RAB4 binding domain of Rabenosyn | 0.53 | 1787 | ||||||||||
| info | 1ZHH_A:B | OR | 1JX6_A | Autoinducer 2-binding periplasmic protein LuxP | 2HJE_A | Autoinducer 2 sensor kinase/phosphatase LuxQ | 1.31 | 2189 | |||||||||||
| info | 1ZHI_A:B | OX | 1M4Z_A | BAH domain of Orc1 | 1Z1A_A | Sir Orc-interaction domain | 0.68 | 1322 | |||||||||||
| info | 2A5T_A:B | OX | 1Y20_A | NMDA receptor R1-4A subunit ligand-binding core | 2A5S_A | NMDA receptor R2A subunit ligand-binding core | 1.28 | 1892 | |||||||||||
| info | 2AJF_A:E | OR | 1R42_A | ACE2 | 2GHV_E | SARS spike protein receptor binding domain | 0.65 | 1704 | |||||||||||
| info | 2B4J_AB:C | OX | 1BIZ_AB | Integrase (HIV-1) | 1Z9E_A(1) | PC4 and SFRS1 interacting protein | 0.99 | 1273 | |||||||||||
| info | 2BTF_A:P | OX | 1IJJ_B | Actin | ATP | 1PNE_ | Profilin | 0.75 | 2063 | ||||||||||
| info | 2FJU_B:A | OG | 2ZKM_X | Phospolipase beta 2 | 1MH1_A | Rac GTPase | GNP | 1.04 | 1245 | ||||||||||
| info | 2G77_A:B | OG | 1FKM_A | GTPase-activating protein GYP1 | 1Z06_A | Ras-related protein Rab-33B | GNP | 1.08 | 2524 | ||||||||||
| info | 2GTP_A:D | OG | 1GFI_A | Alpha-1 subunit Guanine nucleotide-binding protein G(I) | GDP | 2BV1_A | RGS1 | 0.54 | 1442 | ||||||||||
| info | 2HLE_A:B | OR | 2BBA_A | Ephrin B4 receptor | 1IKO_P | Ephrin B2 ectodomain | 1.4 | 2116 | |||||||||||
| info | 2HQS_A:H | OX | 1CRZ_A | TolB | 1OAP_A | Pal | 0.97 | 2333 | |||||||||||
| info | 2VDB_A:B | OX | 3CX9_A | Serum albumin | 2J5Y_A | Peptostreptococcal albumin-binding protein | 0.47 | 1798 | |||||||||||
| info | 2X9A_D:C | OR | 1S62_A(8) | TolA C-terminal domain | 2X9B_A | G3P TolA binding domain | 1.33 | 1571 | |||||||||||
| info | 3BIW_A:E | OX | 3BIX_A | Neuroligin-1 | 2R1D_A | Neuroligin-1-beta | 0.39 | 1191 | |||||||||||
| info | 3BP8_AB:C | OX | 1Z6R_AB | Mlc transcription regulator | 3BP3_A | PTS glucose-specific enzyme EIICB | 0.45 | 1391 | |||||||||||
| info | 3D5S_A:C | OX | 1C3D_A | Complement C3d fragment | 2GOM_A | Fibrinogen-binding protein C-ter domain | 0.56 | 1620 | |||||||||||
| info | 3H2V_A:E | OX | 3MYI_A | Vinculin tail domain | 1WI6_A(8) | Raver1 RRM1 domain | 0.8 | 1263 | |||||||||||
| info | 3P57_AB:P | OX | 3KOV_AB | MEF2A | 3IO2_A | p300 TAZ2 domain | 0.53 | 1291 | |||||||||||
| info | 3P57_CD:P | OX | 3KOV_AB | MEF2A | 3IO2_A | p300 TAZ2 domain | 0.74 | 1177 | |||||||||||
| info | 3P57_IJ:P | OX | 3KOV_AB | MEF2A | 3IO2_A | p300 TAZ2 domain | 0.91 | 1126 | |||||||||||
| info | 4M76_A:B | OR | 1C3D_A | C3D | 1M1U_A | Integrin alpha-M CD11B A-domain | 0.43 | 1046 | |||||||||||
| Medium Difficulty (60) | |||||||||||||||||||
| info | 2DD8_HL:S | AA | 2G75_AB | m396 | 2GHV_E | SARS spike | 2.19 | 1710 | |||||||||||
| info | 3EO1_AB:CF | AA | 3EO0_AB | GC-1008 FAB fragment | 1TGJ_AB | Transforming Growth Factor-Beta 3 | 1.37 | 1630 | Ligand Dimer Created | ||||||||||
| info | 3G6D_LH:A | AA | 3G6A_LH | CNTO607 FAB | 1IK0_A(10) | Interleukin-13 | 1.86 | 1793 | |||||||||||
| info | 3HI6_XY:B | AA | 3HI5_HL | AL-57 FAB fragment | 1MJN_A | Integrin alpha-L I domain | 1.65 | 1871 | |||||||||||
| info | 3L5W_LH:I | AA | 3L7E_LH | C836 FAB | 1IK0_A(11) | Interleukin-13 | 0.48 | 1138 | |||||||||||
| info | 3RJQ_B:A | AA | 3R0M_A | A12 | 3TGR_A | C1086 HIV gp120 | 0.79 | 1734 | |||||||||||
| info | 3V6Z_AB:F | AA | 3V6F_AB | FAB E6 | 3KXS_F | Capsid protein assembly domain | 1.83 | 1922 | |||||||||||
| info | 4ETQ_HL:C | AA | 4EBQ_HL | LA5 | 4E9O_X | vaccinia D8L IMV | 0.47 | 2278 | |||||||||||
| info | 4M3K_B:A | AS | 4M3J_A | cAb-H7S | 4BLM_A | B. licheniformis beta-lactamase | 1.77 | 1588 | |||||||||||
| info | 4POU_B:A | AS | 4POY_A | VHHmetal | 6ETL_A | bovine RNase A | 1.83 | 1313 | |||||||||||
| info | 5CBA_AB:E | AA | 5C2B_HL | 3B4 scFv | 4ZAI_A | CXCL13 | 1.49 | 1790 | |||||||||||
| info | 5E5M_B:A | AS | 5E03_A | H11 | 5E56_A | mouse CTLA-4 | 1.56 | 1341 | |||||||||||
| info | 5HGG_T:A | AS | 5HDO_A | Nb4 | 4FUD_A | uPA | 0.84 | 1969 | |||||||||||
| info | 5HYS_CD:JK | AA | 2XA8_HL | omalizumab (Xolair) | 4GT7_AB | IgE-Fc3-4 | 1.00 | 1332 | |||||||||||
| info | 5KOV_C:AB | AA | 5I30_HL | PL-2 scFv | 5KOU_AB | astrovirus 2 capsid protein spike domain | 1.69 | 1735 | |||||||||||
| info | 5VNW_D:A | AS | 5VNV_A | Nb.b201 | 1E78_A | human serum albumin | 1.49 | 967 | |||||||||||
| info | 5WHK_HL:AB | AA | 5WHJ_HL | DX-2507 | 5BXF_AB | FcRn-B2M | 1.88 | 1850 | |||||||||||
| info | 6A0Z_HL:A | AA | 6A0X_AB | 13D4 | 2FK0_A | H5N1 hemagglutinin head | 1.28 | 1661 | |||||||||||
| info | 6AL0_HL:A | AA | 4YNY_AB | NZ-1 | 6AKQ_A | A. aeolicus site-2 protease homolog with PA tag insertion | 1.89 | 1623 | |||||||||||
| info | 6EY6_I:AB | AS | 5FWO_A | nb130 | 6EY5_AB | P. gingivalis PorM | 1.90 | 1807 | |||||||||||
| info | 1CGI_E:I | EI | 2CGA_B | Bovine chymotrypsinogen | 1HPT_ | PSTI | 2.02 | 2053 | |||||||||||
| info | 1IJK_A:BC | ER | 1AUQ_ | Von Willebrand Factor dom. A1 | 1FVU_AB | Botrocetin | 0.68 | 1648 | |||||||||||
| info | 1JIW_P:I | EI | 1AKL_A | Alkaline metalloproteinase | 2RN4_A(1) | Proteinase inhibitor | 2.07 | 1997 | |||||||||||
| info | 1KKL_ABC:H | ES | 1JB1_ABC | HPr kinase C-ter domain | MSE | 2HPR_ | HPr | 2.2 | 1641 | Receptor Trimer Created | |||||||||
| info | 1M10_A:B | ER | 1AUQ_ | Von willebrand factor dom. A1 | 1M0Z_B | Glycoprotein IB-a | 2.1 | 2097 | |||||||||||
| info | 1NW9_B:A | ER | 1JXQ_A | Capase-9 | 2OPY_A | BIR3-XPIA | 1.97 | 2112 | |||||||||||
| info | 1R6Q_A:C | ER | 1R6C_X | Clp protease subunit ClpA | 2W9R_A | Clp protease adaptor protein ClpS | 1.67 | 1651 | |||||||||||
| info | 1ZM4_A:B | ES | 1N0V_C | Elongation factor 2 | 1XK9_A | Diphtheria toxin A catalytic domain | 2.11 | 1554 | |||||||||||
| info | 2NZ8_A:B | ER | 1MH1_ | Rac GTPase | GNP | 1NTY_A | DH/PH domain of TRIO | 2.13 | 2599 | ||||||||||
| info | 2Z0E_A:B | ER | 2D1I_A | Cysteine protease Atg4B | 1V49_A(1) | Microtubule-associated proteins 1A/1B light chain 3B | 2.15 | 2478 | |||||||||||
| info | 4FZA_A:B | ER | 1UPL_A | MO25 alpha | MSE | 3GGF_A | Serine/threonine-protein kinase MST4 | 2.04 | 1695 | ||||||||||
| info | 4IZ7_A:B | EI | 1ERK_A | Non-phosphorylated ERK | 2LS7_A(1) | PEA-15 Death Effector Domain | 1.56 | 1202 | |||||||||||
| info | 4LW4_AB:C | ES | 4LW2_AB | Cysteine desulfurase CsdA | PLP | 1NI7_A(8) | Cysteine desulfuration protein CsdE | 1.6 | 1610 | Receptor Dimer Created | |||||||||
| info | 1B6C_A:B | OX | 1D6O_A | FKBP binding protein | 1IAS_A | TGFbeta receptor | 1.96 | 1752 | |||||||||||
| info | 1FC2_C:D | OX | 1BDD_ | Staphylococcus Protein A | 1FC1_AB | Human Fc fragment | FUC,GAL,NAG,MAN | 1.69 | 1307 | ||||||||||
| info | 1GP2_A:BG | OG | 1GIA_ | Gi-alpha | GSP | 1TBG_DH | Gi-beta,gamma | 1.65 | 2287 | ||||||||||
| info | 1GRN_A:B * | OG | 1A4R_A | CDC42 GTPase | GDP | 1RGP_ | CDC42 GAP | 1.22 | 2332 | ||||||||||
| info | 1HE8_B:A | OG | 821P_ | Ras GTPase | GTN | 1E8Z_A | PIP3 kinase | 0.92 | 1305 | ||||||||||
| info | 1I2M_A:B | OG | 1QG4_A | Ran GTPase | GNP | 1A12_A | RCC1 | 2.12 | 2779 | ||||||||||
| info | 1IB1_AB:E | OX | 1QJB_AB | 14-3-3 protein | 1KUY_A | Serotonin N-acteylase | COT | 2.09 | 2808 | ||||||||||
| info | 1K5D_AB:C | OG | 1RRP_AB | Ran GTPase | GNP | 1YRG_B | Ran GAP | 1.19 | 2527 | ||||||||||
| info | 1LFD_B:A | OG | 5P21_A | Ras | GNP | 1LXD_A | RalGDS Ras-interacting domain | 1.79 | 1167 | ||||||||||
| info | 1MQ8_A:B | OX | 1IAM_A | ICAM-1 domain 1-2 | 1MQ9_A | Integrin a-L I domain | 1.76 | 1253 | |||||||||||
| info | 1N2C_ABCD:EF | OX | 3MIN_ABCD | Nitrogenase Mo-Fe protein | 2NIP_AB | Nitrogenase Fe protein | 2.13 | 3635 | |||||||||||
| info | 1SYX_A:B | OX | 1QGV_A | Spliceosomal U5 15 kDa protein | 1L2Z_A(1) | CD2 receptor binding protein 2 C-ter fragment | 1.64 | 1293 | |||||||||||
| info | 1WQ1_R:G * | OG | 6Q21_D | Ras GTPase | GCP | 1WER_ | Ras GAP | 1.16 | 2913 | ||||||||||
| info | 1XQS_A:C | OX | 1XQR_A | HspBP1 | 1S3X_A | Hsp70 ATPase domain | ATP | 1.77 | 2350 | ||||||||||
| info | 2CFH_A:C | OX | 1SZ7_A | BET3 | 2BJN_A | TPC6 | 1.55 | 2384 | |||||||||||
| info | 2H7V_A:C | OG | 1MH1_ | Rac GTPase | GNP | 2H7O_A | YpkA | 1.63 | 1574 | ||||||||||
| info | 2HRK_A:B | OX | 2HRA_A | Glutamyl-t-RNA synthetase | 2HQT_A | GU-4 nucleic binding protein | 2.03 | 1595 | |||||||||||
| info | 2OZA_B:A | OX | 3HEC_A | MAP kinase 14 | 3FYK_X | MAP kinase-activated protein kinase 2 | 1.89 | 6248 | |||||||||||
| info | 3AAA_AB:C | OX | 3AA7_AB | Actin capping protein | 1MYO_A(30) | Myotrophin | 1.78 | 1686 | |||||||||||
| info | 3AAD_A:D | OX | 1EQF_A | Double bromodomain | 1TEY_A(13) | Histone chaperone ASF1 | 2 | 1461 | |||||||||||
| info | 3BX7_A:C | OX | 3BX8_A | Lipocalin 2 | 3OSK_A | CTLA-4 extracellular domain | 1.63 | 2349 | |||||||||||
| info | 3CPH_G:A | OG | 3CPI_G | Rab GDP-dissociation inhibitor | 1G16_A | Ras-related protein Sec4 | GNP | 2.12 | 1685 | ||||||||||
| info | 3DAW_A:B | OX | 1IJJ_A | Alpha actin | ATP | 2HD7_A(5) | Twinfilin-1 C-terminal domain | 1.49 | 2323 | ||||||||||
| info | 3R9A_AC:B | OR | 1H0C_AB | Alanine-glyoxylate aminotransferase | PLP,LLP | 2C0M_A | PEX5P TPR repeat domain | 1.91 | 1926 | Receptor Dimer Created | |||||||||
| info | 3S9D_B:A | OR | 1N6U_A(15) | IFNAR2 | 1ITF_A(9) | IFNa2 | 1.69 | 1841 | |||||||||||
| info | 3SZK_DE:F | OX | 3ODQ_AB | MetHaemoglobin | HEM | 2H3K_A | ISDH-N1 | 2.1 | 1263 | ||||||||||
| info | 4JCV_ADBC:E | OX | 1VDD_ABCD | Recombinational repair protein RecR | 1W3S_A | DNA repair protein RecO | 1.62 | 1949 | |||||||||||
| Difficult (35) | |||||||||||||||||||
| info | 2FJG_HL:VW | AA | 2FJF_HL | G6 | 4KZN_AB | VEGF | 2.51 | 1678 | Ligand Dimer Created | ||||||||||
| info | 4DW2_HL:U | AA | 4DVB_AB | mAb-112 | 4DVA_U | uPA | 2.27 | 2038 | |||||||||||
| info | 5C7X_HL:A | AA | 5D7S_HL | MOR04357 | 2GMF_A | GM-CSF | 2.31 | 2523 | |||||||||||
| info | 1ACB_E:I | EI | 2CGA_B | Chymotrypsin | 1EGL_ | Eglin C | 2.26 | 1544 | |||||||||||
| info | 1F6M_A:C | ES | 1CL0_A | Thioredoxin reductse | FAD | 2TIR_A | Thioredoxin 1 | 4.9 | 1821 | ||||||||||
| info | 1FQ1_A:B | ES | 1B39_A | CDK2 kinase | ATP,ACE | 1FPZ_F | CDK inhibitor 3 | 3.41 | 1832 | ||||||||||
| info | 1JK9_B:A | ES | 1QUP_A | CCS metallochaperone | 2JCW_A | SOD1 superoxide dismutase | 2.51 | 2130 | |||||||||||
| info | 1JMO_A:HL | ER | 1JMJ_A | Heparin cofactor | 2CN0_HL | Thrombin | 3.21 | 3461 | |||||||||||
| info | 1JZD_AB:C | ER | 1JZO_AB | DsbC disurfide bond isomerase | 1JPE_A | DsbD disulfide bond isomerase | 2.71 | 2026 | |||||||||||
| info | 1PXV_A:C | EI | 1X9Y_A | Cystein protease | 1NYC_A | Cystein protease inhibitor | 2.63 | 2336 | |||||||||||
| info | 1ZLI_A:B | EI | 1KWM_A | Carboxypeptidase B | 2JTO_A(6) | Tick carboxypeptidase inhibitor | 2.53 | 2084 | |||||||||||
| info | 2IDO_A:B | ES | 1J54_A | DNA polymerase III e exonuclease domain | 1SE7_A(1) | HOT protein (P1 phage) | 2.79 | 1953 | |||||||||||
| info | 2O3B_A:B | EI | 1ZM8_A | NucA nuclease | 1J57_A | NuiA nuclease inhibitor | 3.13 | 1675 | |||||||||||
| info | 2OT3_B:A | ER | 1YZU_A | Rab21 GTPase | GNP | 1TXU_A | Rabex-5 VPS9 domain | 2.79 | 2306 | ||||||||||
| info | 3FN1_B:A | ER | 2EDI_A(5) | UQ_con domain from NEDD8-conjugating enzyme UBE2F | 2LQ7_A | NEDD8-activaating enzyme E1 catalytic subunit | MSE | 3.65 | 1897 | ||||||||||
| info | 3H11_BC:A | ER | 4JJ7_AB | Caspase-8 | ASA,ACE,1MH,B3L,HLX,1U8 | 3H13_A | c-FLIPL protease-like domain | 3.79 | 3169 | ||||||||||
| info | 4GAM_AFBGCH:D | ER | 1XVB_ABCDEF | Methane monooxygenase hydroxylase | 1CKV_A(9) | Methane monooxygenase regulatory protein B | 5.79 | 6671 | |||||||||||
| info | 1ATN_A:D | OX | 1IJJ_B | Actin | ATP | 3DNI_ | Dnase I | 3.28 | 1774 | ||||||||||
| info | 1BKD_R:S | OG | 1CTQ_A | Ras GTPase | 1GNP | 2II0_A | Son of sevenless | 2.86 | 3163 | ||||||||||
| info | 1DE4_AB:CF | OX | 1A6Z_AB | beta2-microglobulin | 1CX8_AB | Transferrin receptor ectodom. | 2.59 | 2066 | |||||||||||
| info | 1E4K_AB:C | OR | 3AVE_AB | FC fragment of human IgG 1 | NAG,FUC,MAN | 1FNL_A | Human FCGR III | 2.6 | 1634 | ||||||||||
| info | 1EER_A:BC | OR | 1BUY_A | Erythropoietin | 1ERN_AB | EPO receptor | 2.44 | 3347 | Ligand Dimer Created | ||||||||||
| info | 1FAK_HL:T | OR | 1QFK_HL | Coagulation factor VIIa | 1TFH_B | Soluble tissue factor | 6.18 | 3363 | |||||||||||
| info | 1H1V_A:G | OX | 1IJJ_B | Actin | ATP | 1D0N_B | Gelsolin | 6.62 | 2071 | ||||||||||
| info | 1IBR_A:B | OG | 1QG4_A | Ran GTPase | GDP | 1F59_A | Importin beta | 2.54 | 2270 | ||||||||||
| info | 1IRA_Y:X | OR | 1G0Y_R | Interleukin-1 receptor | 1ILR_1 | Interleukin-1 receptor antagonist protein | 8.38 | 3367 | |||||||||||
| info | 1R8S_A:E | OG | 1HUR_A | Arf1 GTPase | GDP | 1R8M_E | Sec 7 domain | 3.73 | 2986 | ||||||||||
| info | 1RKE_A:B | OX | 1SYQ_A | Vinculin head | 3MYI_A | Vinculin tail | 4.25 | 2614 | |||||||||||
| info | 1Y64_A:B | OX | 2FXU_A | Actin | ATP | 1UX5_A | BNI1 protein | 4.69 | 2745 | ||||||||||
| info | 2C0L_A:B | OX | 1FCH_A | PTS1 and TRP region of PEX5 | 1C44_A | SCP2 | 2.62 | 2013 | |||||||||||
| info | 2I9B_E:A | OR | 1YWH_A | Urokinase plasminogen activator surface receptor | 2I9A_A | Urokinase-type plasminogen activator | 3.79 | 2371 | |||||||||||
| info | 2J7P_A:D | OX | 1NG1_A | SRP GTPase Ffh | GDP | 2IYL_D | Cell division protein FtsY | GDP | 2.67 | 3008 | |||||||||
| info | 3AAD_A:B | OX | 1EQF_A | Double bromodomain | 1TEY_A(4) | Histone chaperone ASF1 | 4.37 | 1654 | |||||||||||
| info | 3F1P_A:B | OX | 1P97_A(9) | HIF2 alpha C-terminal PAS domain | 1X0O_A(5) | ARNT C-terminal PAS domain | 2.52 | 1919 | |||||||||||
| info | 3L89_ABC:M | OR | 3L88_ABC | Ad21 fiber knob | 1CKL_A | CD46 SCR1 and SCR2 domains | 2.51 | 2167 | |||||||||||
| a Complex category labels: | |||||||||||||||||||
| EI = Enzyme-Inhibitor | |||||||||||||||||||
| ES = Enzyme-Substrate | |||||||||||||||||||
| ER = Enzyme complex with a regulatory or accessory chain | |||||||||||||||||||
| AA = Antibody-Antigen | |||||||||||||||||||
| AS = Antigen - Single domain Antibody | |||||||||||||||||||
| OG = Others, G-protein containing | |||||||||||||||||||
| OR = Others, Receptor containing | |||||||||||||||||||
| OX = Others, miscellaneous | |||||||||||||||||||
| b RMSD of Ca atoms of interface residues calculated after finding the best superposition of bound and unbound interfaces. | |||||||||||||||||||
| c Change in Accessible Surface Area upon complex formation calculated using NACCESS. | |||||||||||||||||||
| HETATMs column lists cofactors and small ligands present in the downloadable cleaned-up files. | |||||||||||||||||||
| We included those small molecules important for binding and other compounds on surfaces. | |||||||||||||||||||
| Glycosylations not crucial for binding were excluded. | |||||||||||||||||||
| Multimer column contains comments pertaining to any multimers created by symmetry prior to docking | |||||||||||||||||||
| if the asymmetric unit did not contain the full biologically relevant molecule. | |||||||||||||||||||
| * Cases marked with the asterisk are those that would be considered redundant under the SCOP Superfamily-Superfamily | |||||||||||||||||||
| pair non-redundancy criterion. | |||||||||||||||||||
| ? Please follow the "+info" link for more information on those cases | |||||||||||||||||||
| The previous version of the Benchmark (5.0) can be found here. | |||||||||||||||||||
| The following Benchmark 5.0 cases were revised for Benchmark 5.5: | |||||||||||||||||||
| Antibody-Antigen complexes without unbound antibodies removed (were called AB) | |||||||||||||||||||
| 1BVK removed | |||||||||||||||||||
| 1BGX removed | |||||||||||||||||||